The European Society for Medical Oncology (ESMO) is calling on European politicians to voice their support for a decisive step to help ensure cancer patients receive the best possible treatment.
At a meeting of the European Commission today representatives from all EU Member States met in Brussels to consider the status of medical oncology as a recognized specialty under EU law.
Such recognition is an essential step in providing optimal treatment to the millions of Europeans who have cancer or who develop cancer every year, says Dr. Jose Baselga, ESMO President-Elect. It would enable the free movement of medical oncologists within EU Member States, with their professional qualifications being automatically recognized.
A determining factor for optimal cancer treatment and research is the level of training, knowledge and skills of oncology professionals, says Dr. Baselga.
Medical oncologists are doctors who specialize in taking care of cancer patients. They have training in internal medicine, and subsequent specialization in the comprehensive management of patients with malignancies.
Medical oncologists are trained in the scientific basis of cancer treatment, prevention, screening, and diagnosis. Hospitals in every European country, and around the world, employ medical oncologists to help treat their patients.
Medical oncology is recognized as a specialty in most of the EU Member States, the United States and many other countries around the world, says Dr. Adamos Adamou, co-chair of the European Members of Parliament Against Cancer (MAC). We believe it is time the EU joined them.
Working in multidisciplinary teams with surgeons and radiation oncologists, medical oncologists are responsible for the systemic treatment of cancer patients with chemotherapy, hormonal therapy, immune and targeted therapies, as well as supportive care. Medical oncologists also engage in clinical cancer research in the
|Contact: Gracemarie Bricalli|
European Society for Medical Oncology